A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: A diffusion and perfusion MRI study

Stroke

Volumn 29, Issue 4, 1998, Pages 850-858

  Tatlisumak, Turgut ^a,c,d   Carano, Richard A D ^b   Takano, Kentaro ^a,c   Opgenorth, Terry J ^e   Sotak, Christopher H ^b   Fisher, Marc ^a,c  

^a Medical Center   (United States)

^b Worcester Polytechnic Institute   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e NONE

Author keywords

Cerebral ischemia; Endothelins; Magnetic resonance imaging; Middle cerebral artery; Rats

Indexed keywords

ATRASENTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CIRCULATION; BRAIN ISCHEMIA; BRAIN PERFUSION; CALCULATION; DIFFUSION; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REPERFUSION;

EID: 0031945018     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.4.850     Document Type: Article

References (54)

1. Masaki T, Vane JR, Vanhoutte PM. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev. 1994;46:137-142.
2. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-415.
3. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke. 1992;23: 1014-1016.
4. Estrada V, Téllez MJ, Moya J, Fernández-Durango R, Egido J, Cruz AF. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens. 1994;7:1085-1089.
5. Hirata Y, Matsunaga T, Ando K, Furukawa T, Tsukagoshi H, Maruma F. Presence of endothelin-1-like immunoreactivity in human cerebrospinal fluid. Biochem Biophys Res Commun. 1990;166:1274-1278.
6. Barone FC, Willette RN, Yue T-L, Feuerstein G. Therapeutic effects of endothelin receptor antagonists in stroke. Neurol Res. 1995;17:259-264.
7. Opgenorth TJ. Endothelin receptor antagonism. Adv Pharmacol. 1995; 33:1-65.
8. Fisher M, Prichard JW, Warach S. New magnetic resonance techniques for acute ischemic stroke. JAMA. 1995;274:908-911.
9. Warach S, Li W, Ronthal M, Edelman RR. Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography. Radiology. 1992;182:41-47.
10. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol. 1995;37:231-241.
11. Warach S, Dashe JF, Edelmann RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996;16: 53-59.
12. Le Bihan D, Breton E, Lallemand D, Grenier P, Canabis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurological disorders. Radiology. 1986;161:401-407.
13. Hamberg LM, Macfarlane R, Tasdemiroglu E, Boccalini P, Hunter GJ, Belliveau JW, Moskowitz MA, Rosen BR. Measurement of cerebrovascular changes in cats after transient ischemia using dynamic magnetic resonance imaging. Stroke. 1993;24:444-451.
14. A-selective receptor antagonist. J Pharmacol Exp Ther. 1996;276:473-481.
15. A selective endothelin receptor antagonists, I: discovery of A-127722. J Med Chem. 1996;39:1039-1048.
16. Dardzinski BJ, Sotak CH, Fisher M, Hasegawa Y, Li L, Minematsu K. Apparent diffusion coefficient mapping of experimental focal cerebral ischemia using diffusion-weighted echo-planar imaging. Magn Reson Med. 1993;30:318-325.
17. Takano K, Latour LL, Formato JE, Carano RAD, Helmer KG, Hasegawa Y, Sotak CH, Fisher M. The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann Neurol. 1996;39:308-318.
18. Zea Longa E, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20: 84-91.
19. Lin T-N, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal ischemia model in rats. Stroke. 1993;24: 117-121.
20. Patel TR. Therapeutic potential of endothelin antagonists in cerebrovascular disease. CNS Drugs. 1996;5:293-310.
21. Adner M, Jansen I, Edvinsson L. Endothelin-A receptors mediate contraction in human cerebral, meningeal, and temporal arteries. J Autonom Nerv Syst. 1994;49:S117-S121.
22. Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J. Endothelin-1 induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab. 1993;13:276-284.
23. Sharkey J, Butcher JP, Kelly JS. Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801. J Autonom Nerv Syst. 1994;49:S177-S185.
24. Fuxe K, Kurosawa N, Cintra A, Hallström A, Goiny M, Agnati LF, Ungerstedt U. Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anesthetized rat. Exp Brain Res. 1992; 88:131-139.
25. Fuxe K, Cintra A, Andbjer B, Änggård E, Goldstein M, Agnati LF. Centrally administered endothelin 1 produced lesions in the brain of the male rat. Acta Physiol Scand. 1989;137:155-156.
26. Nikolov R, Rami A, Krieglstein J. Endothelin-1 exacerbates focal cerebral ischemia without exerting neurotoxic action in vitro. Eur J Pharmacol. 1993;248:205-208.
27. Feuerstein G, Gu J, Ohlstein EH, Barone FC, Yue T. Peptidic endothelin-1 receptor antagonist, BQ-123, and neuroprotection. Peptides. 1994;15:467-469.
28. Patel TR, Galbraith S, Graham DI, Hallak H, Doherty AM, McCulloch J. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischemia. J Cereb Blood Flow Metab. 1996;16:950-958.
29. 14C] iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1981;1:61-81.
30. Thiemermann C, Lidbury PS, Thomas GR, Vane JR. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit. J Cardiovasc Pharmacol. 1989;13(suppl 5):S138-S141.
31. B receptor. Br J Pharmacol. 1993;109:530-534.
32. Lustig HS, Chan J, Greenberg DA. Comparative neurotoxic potential of glutamate, endothelins, and platelet-activating factor in cerebral cortical cultures. Neurosci Lett. 1992;139:15-18.
33. 3H]D aspartate from cultured cerebellar granule cells. Biochem Biophys Res Commun. 1990;167:593-599.
34. Marsault R, Vigne P, Breittmayer J-P, Frelin C. Astrocytes are target cells for endothelins and sarafotoxin. J Neurochem. 1990;54:2142-2144.
35. Zhang W, Sakai N, Yamada H, Fu T, Nozawa Y. Endothelin-1 induces intracellular calcium rise and inositol 1,4,5-triphosphate formation in cultured rat and human glioma cells. Neurosci Lett. 1990;112:199-204.
36. Chan J, Greenberg DA. Endothelin and calcium signaling in NG108-15 neuroblastomaxglioma cells. J Pharmacol Exp Ther. 1991;258:524-530.
37. Goadsby PJ, Adner M, Edvinsson L. Characterization of endothelin receptors in the cerebral vasculature and their lack of effect on spreading depression. J Cereb Blood Flow Metab. 1996;16:698-704.
38. Busto R, Dietrich WD, Globus MY-T, Ginsberg MD. The importance of brain temperature in cerebral ischemic injury. Stroke. 1989;20: 1113-1114.
39. Le Bihan D, Delannoy J, Levin RL. Temperature mapping with MR imaging of molecular diffusion: application to hyperthermia. Radiology. 1991;171:853-857.
40. Hasegawa Y, Latour LL, Sotak CH, Dardzinski BJ, Fisher M. Temperature dependent change of apparent diffusion coefficient of water in normal and ischemic brain of rats. J Cereb Blood Flow Metab. 1994;14: 383-390.
41. Garcia JH. Mechanisms of cell death in ischemia. In: Caplan LR, ed. Brain Ischemia: Basic Concepts and Clinical Relevance. London, England: Springer-Verlag; 1995:7-18.
42. Meden P, Tatlisumak T, Takano K, Carano RAD, Hadley SJ, Fisher M. Thrombolysis with recombinant Desmodus saliva plasminogen activator (rDSPA) in a rat embolic stroke model. Cerebrovasc Dis. 1996;6:190. Abstract.
43. Takano K, Carano RAD, Tatlisumak T, Meiler MR, Sotak CH, Kleinert HD, Fisher M. The efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology. 1997;48(suppl 2):A409. Abstract.
44. Tatlisumak T, Takano K, Carano RAD, Fisher M. Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging. Stroke. 1996;27:2292-2298.
45. Koketsu N, Berlove DJ, Moskowitz MA, Kowall NW, Caday CG, Finklestein SP. Pretreatment with intraventricular basic fibroblast growth factor (bFGF) decreases infarct size following focal cerebral ischemia in rats. Ann Neurol. 1994;35:451-457.
46. Fisher M, Meadows M-E, Do T, Weise J, Trubetskoy V, Charette M, Finklestein S. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1995;15:953-959.
47. Tanaka R, Miyasaka Y, Yada K, Ohwada T, Kameya T. Basic fibroblast growth factor increases regional blood flow and reduces infarct size after experimental ischemia in a rat model. Stroke. 1995;26:2154-2159.
48. Jiang N, Finklestein SP, Do T, Caday CG, Charette M, Chopp M. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/ reperfusion in the rat. J Neurol Sci. 1996;139:173-179.
49. Takano K, Tatlisumak T, Formato JE, Carano RAD, Bergmann AG, Pullan LM, Bare TM, Sotak CH, Fisher M. A glycine site antagonist. ZD9379, attenuates infarct size in experimental focal ischemia: post-mortem and diffusion mapping studies. Stroke. 1997;28:1255-1263.
50. Qui H, Hedlund LW, Benveniste H, Gewalt SL, Johnson GA. Evaluation of a glycine antagonist in rat focal ischemia by diffusion-weighted MR microscopy. In: Proceedings of the International Society for Magnetic Resonance in Medicine. 1996;4:505. Abstract.
51. Lo EH, Matsumoto K, Pierce AR, Garrido L, Luttinger D. Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. J Cereb Blood Flow Metab. 1994; 14:597-603.
52. Lo EH, Pierce AR, Mandeville JB, Rosen BR. Neuroprotection with NBQX in rat focal cerebral ischemia: effects on ADC probability distribution functions and diffusion-perfusion relationships. Stroke. 1997;28: 439-446.
53. Haynes WG, Webb DJ. The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci. 1993;84: 485-500.
54. Clarke JG, Benjamin N, Larkin SW, Webb DJ, Davies GJ, Maseri A. Endothelin is a potent long-lasting vasoconstrictor in men. Am J Physiol. 1989;257:H2033-H2035.